Skip to main content
KROSHealthcare

Keros Therapeutics Inc (KROS) Insider Trading

In the last 90 days, 5 Keros Therapeutics Inc (KROS) insiders reported 1 open-market purchase totaling $10,270 and 4 sales totaling $101,136. The most recent open-market purchase was reported on Aug 17, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$10,270
Corporate buyers
1
Latest transaction
Aug 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 18, 2026Annita TaniniCorp. Controller & VP, FinanceSale1,224$10.29$12,595
Aug 18, 2026Esther ChoChief Legal OfficerSale4,485$10.29$46,151
Aug 18, 2026Lorena Raquel LernerChief Scientific OfficerSale3,568$10.29$36,715
Aug 18, 2026Charles W. NewtonDirectorSale551$10.30$5,675
Aug 17, 2026Jean Jacques BienaimeDirectorOpen Market Purchase1,000$10.27$10,270
Jul 15, 2026Jean Jacques BienaimeDirectorOpen Market Purchase1,000$10.61$10,610
Jun 15, 2026Jean Jacques BienaimeDirectorOpen Market Purchase1,000$10.19$10,190
Jun 11, 2026Charles W. NewtonDirectorSale550$10.04$5,522
Jun 4, 2026Julius KnowlesDirectorSale2,625$10.73$28,166
Jun 4, 2026Nima FarzanDirectorSale2,625$10.73$28,166

Common questions

KROS insider trading FAQ

Are KROS insiders buying or selling?
Over the last 90 days, KROS insiders were net sellers, reporting $10,270 of open-market purchases and $101,136 of sales.
When was the last KROS insider purchase?
The most recent open-market purchase of Keros Therapeutics Inc stock by an insider was reported on Aug 17, 2026, one of 1 purchase in the last 90 days.
Where does KROS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Keros Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.